9.09
China Pharma Holdings, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
5.96
FY23:
6.00
FY24:
3.27
FY25:
2.35
(positive)
Change from FY21 to FY25
millions USD
FY21:
13.6
FY22:
11.8
FY23:
10.5
FY24:
11.6
FY25:
28.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
22.6
FY22:
17.8
FY23:
16.5
FY24:
14.9
FY25:
31.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
10.5
FY22:
12.7
FY23:
6.82
FY24:
5.02
FY25:
7.40
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.12
FY22:
0.75
FY23:
2.19
FY24:
2.12
FY25:
0.86
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.02
FY22:
4.29
FY23:
7.45
FY24:
7.75
FY25:
22.7
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
22.6
FY22:
17.8
FY23:
16.5
FY24:
14.9
FY25:
31.0
All amounts in millions USD